Safely2Prosperity Public Health Bio Attack Intelligence Unit
Hon. John Norris JD, MBA
FDA Former #2; 20x Board Member; Executive Chair Safely2Prosperity; formerly managed ~14,000 EEs and ~$6B budget; ~30,000 LinkedIn followers; Former Harvard Life Sci and Mgt Faculty Member; facilitated raising $Billions
by Dr. Joshua Sinai
This bi-weekly “Bio Attack Risk Report” brings politicians, government agency heads, and business executives (including leaders of not-for-profit enterprises) up to date on significant news regarding the risks associated with bio attacks at all levels of society, from enterprises to regions to nations to international (pandemics), and whether nature-made or human-manufactured by terrorists.?
CDC COVID Data Tracker
As of October 12, 2024, the CDC’s COVID-19 Update for the United States reported a decline in test positivity from the previous week of 6.3% (versus 7.6%); emergency department visits diagnosed as COVID-19 of 0.7% (versus 0.8 the previous week), the rate per 100,000 hospitalizations of 3.2 (as opposed to 3.7 the previous week), and the % of all deaths in the U.S. due to Covid-19 of 1.5% (as opposed to 1.8% the previous week).?
CDC Traveler’s Health
The CDC’s Travel Health Notices (NHNs) inform travelers about global health risks during outbreaks, special events or gatherings, and natural disasters. They also advise travelers about protective actions to prevent infection or adverse health effects. The NHN’s four levels consist of Level 4 – Avoid All Travel Advisory, Level 3 - Reconsider Nonessential Travel, Level 2 - Practice Enhanced Precautions, and Level 1 - Practice Usual Precautions. In October 2024, no Level 4 advisory was issued, but a Level 3 advisory was issued for nonessential travel to the Republic of Rwanda, which was experiencing an outbreak of Marburg virus disease. In late September 2024, a Level 2 advisory was issued for an outbreak of Clade I Mpox in Central and Eastern Africa, and an outbreak of Oropouche in Cuba.?
World Health Organization Data – WHO COVID-19 Dashboard
From 28 days before to October 6, 2024, the number of COVID-19 cases worldwide reported to WHO was 322,343, an increase of 63,728 from the previous period.?
领英推荐
COVID-19 Real-Time Learning Network – CDC and IDSA
COVID-19 Variant Update
As of September 17, 2024, the SARS-CoV-2 Omicron variants KP.2, KP.2.3, KP.3 and KP.3.1.1, as well as LB.1, are considered as high prevalence in the United States. CDC Nowcast projections estimated that the KP.3.1.1 variant accounted for approximately 53% of new COVID-19 illnesses in the US. As of September 17, the estimated percentage of illnesses caused by KP.2.3 was 12.2% (a slight decrease from the previous four-week period), and the estimated percentage of illnesses caused by LB.1 was 10.0% (also a slight decrease from the previous four-week period).
Kathy Katela, “3 Things to Know About XEC, the Latest COVID Strain,” Yale Medicine, October 18, 2024?
The newest variant of COVID-19 is called XEC. It is a subvariant of the SARS-CoV-2 Omicron strain, which has spawned multiple descendants since it surfaced in the U.S. in 2021. XEC first appeared in Germany in June 2024 before spreading rapidly throughout other parts of Europe.
Dr. Joshua Sinai is a Member of Safely2Prosperity’s Advisory Board. He may be reached for
comment at text: 301-385-8540.
? 2024 Safely2Prosperity LLC. ALL RIGHTS RESERVED.
"Trailblazer in the field of patient-centred healthcare, someone whose life mission has been to alleviate pain, uplift the poor and defend the highest ethical standards in medicine" - ChatGPT
4 个月